Prognosis and cardiovascular morbidity and mortality in prospective study of hypertensive patients with obstructive sleep apnea syndrome in St Petersburg, Russia

Medical Science Monitor

Volumn 17, Issue 3, 2011, Pages 8-

  Korostovtseva, Lyudmila S ^a   Sviryaev, Yurii V ^a   Zvartau, Nadezhda E ^a   Konradi, Alexandra O ^a   Kalinkin, Alexander L ^b  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^b Clinical Hospital No 83   (Russian Federation)

Author keywords

Hypertension; Mortality; Obstructive sleep apnea; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PROGNOSIS; PROSPECTIVE STUDY; RUSSIAN FEDERATION; SLEEP APNEA SYNDROME;

EID: 79952376660     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881448     Document Type: Article

References (33)

1. Shahar E, Whitney CW, Redline S et al: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med, 2001; 163(1): 19-25
2. Lüthje L, Andreas S: Obstructive sleep apnea and coronary artery disease. Sleep Med Rev, 2008; 12(1): 19-31
3. Shamsuzzaman AS, Gersh BJ, Somers VK: Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA, 2003; 290(14): 1906-14
4. Lattimore JD, Celermajer DS, Wilcox I: Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol, 2003; 41(9): 1429-37
5. Neau JP, Paquereau J, Meurice JC et al: Stroke and sleep apnoea: cause or consequence? Sleep Med Rev, 2002; 6(6): 457-69
6. Hanly PJ, George CF, Millar TW, Kryger MH: Heart rate response to breath-hold, valsalva and Mueller maneuvers in obstructive sleep apnea. Chest, 1989; 95(4): 735-39
7. Heitmann J, Ehlenz K, Penzel T et al: Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J, 2004; 23(2): 255-62
8. Narkiewicz K, Pesek CA, Kato M: Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension, 1998; 32(6): 1039-43
9. Marshall NS, Wong KKH, Liu PY et al: Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep, 2008; 31(8): 1079-85
10. Young T, Finn L, Peppard PE et al: Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. Sleep, 2008; 31(8): 1071-78
11. Lavie P: Mortality in sleep apnea syndrome: a review of the evidence. Eur Respir Rev, 2007; 16(106): 203-10
12. Logan AG, Perlikowski SM, Mente A et al: High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens, 2001; 19(12): 2271-77
13. Peker Y, Kraiczi H, Hedner J et al: An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J, 1999; 14(1): 179-84
14. Wein AM, Eligulashvili TS, Polouektov MG: Sleep apnea syndrome and the other sleep related breathing disturbances: clinical features, diagnosis and treatment. Moscow: Eidos Media, 2002
15. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005; 365(9464): 1046-53
16. Lavie P, Herer P, Lavie L: Mortality risk factors in sleep apnoea: a matched case-control study. J Sleep Res, 2007; 16(1): 128-34
17. Peker Y, Carlson J, Hedner J: Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J, 2006; 28(3): 596-602
18. Valham F, Mooe T, Rabben T: Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation, 2008; 118(9): 955-60
19. Rybczynski M, Koschyk D, Karmeier A: Frequency of sleep apnea in adults with the Marfan syndrome. Am J Cardiol, 2010; 105(12): 1836-41
20. Milleron O, Pillière R, Foucher A et al: Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J, 2004; 25(9): 728-34
21. Lavie P, Herer P, Hoffstein V: Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ, 2000; 320(7233): 479-82
22. Netzer NC, Stoohs RA, Netzer CM et al: Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med, 1999; 131(7): 485-91
23. Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep, 1991; 14(6): 540-45
24. Somers VK, White DP, Amin R et al: Sleep Apnea and Cardiovascular Disease. An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing Council. Circulation published online Jul 28, 2008
25. Schahin SP, Nechanitzky T, Dittel C et al: Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome. Med Sci Monit, 2008; 14(3): CR117-21
26. Harsch IA, Hahn EG, Konturek PC: Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit, 2005; 11(3): RA70-75
27. Gami AS, Howard DE, Olson EJ, Somers VK: Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med, 2005; 352(12): 1206-14
28. Serizawa N, Yumino D, Kajimoto K et al: Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol, 2008; 102(8): 1064-68
29. Kasai T, Narui K, Dohi T et al: Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest, 2008; 133(3): 690-96
30. Peker Y, Hedner J, Johansson A, Bende M: Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP therapy. Sleep, 1997; 20(8): 645-53
31. Gonçalves SC, Martinez D, Gus M et al: Obstructive sleep apnea and resistant hypertension: a case-control study. Chest, 2007; 132(6): 1858-62
32. Lavie P, Hoffstein V: Sleep apnea syndrome: a possible contributing factor to resistant. Sleep, 2001; 24(6): 721-25
33. Lopes NH, Paulitsch FS, Pereira AC et al: Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study. Coron Artery Dis, 2008; 19(6): 383-88